NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 7.93% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.60% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.48% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.40% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 4.37% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.74% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.24% |
| 2269 | WuXi Biologics | Healthcare | Biotechnology | 3.20% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.08% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 2.97% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 2.93% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.92% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.86% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.70% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.70% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.59% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.52% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.51% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.35% |